渤健公司高管在美银医疗健康大会上表示,业界普遍承认IgA肾病(IgAN)治疗领域的市场动态已变得相当拥挤。该领域预计将迎来“数项”通过加速审批通道上市的新疗法。
渤健公司高管在美银医疗健康大会上表示,业界普遍承认IgA肾病(IgAN)治疗领域的市场动态已变得相当拥挤。该领域预计将迎来“数项”通过加速审批通道上市的新疗法。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.